We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+17.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.66B
AUM Growth
+$537M
Cap. Flow
-$23.3M
Cap. Flow %
-0.5%
Top 10 Hldgs %
6.44%
Holding
1,468
New
106
Increased
604
Reduced
314
Closed
113

Top Buys

Rank Stock Value
1
XRX icon
Xerox
XRX
+$14.1M
2
DAN icon
Dana Inc
DAN
+$12.5M
3
OPEN icon
Opendoor
OPEN
+$10.6M
4
CSCO icon
Cisco
CSCO
+$7.51M
5
JBLU icon
JetBlue
JBLU
+$7.32M

Sector Composition

Rank Sector Weight
1 Financials 26.7%
2 Consumer Discretionary 12.75%
3 Industrials 12.29%
4 Technology 10.9%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNNA icon
1251
Hennessy Advisors
HNNA
$78.5M
$93.6K ﹤0.01%
13,951
+576
+4% +$3.78K
CETX icon
1252
Cemtrex
CETX
$4.84M
0
TBHC
1253
DELISTED
The Brand House Collective
TBHC
$90.6K ﹤0.01%
30,000
-20,000
-40% -$43.7K
STOK icon
1254
Stoke Therapeutics
STOK
$2.11B
$89.9K ﹤0.01%
+17,100
New +$73.1K
NSTG
1255
DELISTED
NanoString Technologies, Inc.
NSTG
$89.8K ﹤0.01%
120,000
-50,000
-29% -$52.8K
DTIL icon
1256
Precision BioSciences
DTIL
$207M
$89.6K ﹤0.01%
8,180
DMRA
1257
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$88.6K ﹤0.01%
4,924
-2,000
-29% -$30.8K
MAIA icon
1258
MAIA Biotechnology
MAIA
$86.3M
$88.6K ﹤0.01%
75,700
+24,100
+47% +$38.9K
SCTL
1259
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$87.5K ﹤0.01%
249,600
ALIM
1260
DELISTED
Alimera Sciences
ALIM
$86.4K ﹤0.01%
20,000
XLO icon
1261
Xilio Therapeutics
XLO
$60.3M
$85.5K ﹤0.01%
11,106
+3,214
+41% +$63.6K
NTWK icon
1262
NetSol Technologies
NTWK
$50.6M
$85.1K ﹤0.01%
39,596
+3,456
+10% +$6.94K
INUV icon
1263
Inuvo
INUV
$17M
$85K ﹤0.01%
20,000
AWX icon
1264
Avalon Holdings
AWX
$10.1M
$84.8K ﹤0.01%
35,500
BRLT icon
1265
Brilliant Earth
BRLT
$21.6M
$84.8K ﹤0.01%
22,800
MGLD icon
1266
Marygold Companies
MGLD
$46.1M
$84.6K ﹤0.01%
79,767
CURO
1267
DELISTED
CURO Group Holdings Corp.
CURO
$84.1K ﹤0.01%
105,167
BZFD icon
1268
BuzzFeed
BZFD
$96.7M
$83K ﹤0.01%
83,000
RBOT
1269
DELISTED
Vicarious Surgical
RBOT
$82.5K ﹤0.01%
7,500
PRST
1270
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$82.4K ﹤0.01%
155,000
+80,000
+107% +$82.7K
XGN icon
1271
Exagen
XGN
$166M
$81.2K ﹤0.01%
40,800
RENT
1272
Rent the Runway
RENT
$124M
$81K ﹤0.01%
7,675
-2,500
-25% -$30.9K
STRR
1273
DELISTED
Star Equity Holdings
STRR
$80K ﹤0.01%
15,678
BBGI icon
1274
Beasley Broadcasting Group
BBGI
$40M
$78.9K ﹤0.01%
4,491
-1,750
-28% -$27.2K
JRSH icon
1275
Jerash Holdings
JRSH
$63.5M
$78.6K ﹤0.01%
25,600

Similar funds

Bridgeway Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bridgeway Capital Management held 1,468 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q4 2023 filing shows 106 new, 604 increased, 314 reduced and 113 closed positions. Its largest new stake was Xerox: 953,092 shares worth $17.5M. The largest sale was Textainer Group Holdings limited, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q4 2023 buy was Xerox: 953,092 shares worth $17.5M.
  • Bridgeway Capital Management added most to Opendoor in Q4 2023, an estimated $10.6M increase.
  • Bridgeway Capital Management's biggest Q4 2023 reduction was Textainer Group Holdings limited, cutting an estimated $19.1M.
  • Bridgeway Capital Management fully exited VERITIV CORPORATION in Q4 2023, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.66B portfolio in Q4 2023.
  • Bridgeway Capital Management opened 106 new positions and closed 113 in Q4 2023.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.